Novocure Total Stockholder Equity from 2010 to 2025
| NVCR Stock | USD 21.00 0.24 1.13% |
Total Stockholder Equity | First Reported 2013-12-31 | Previous Quarter 361.8 M | Current Value 360.8 M | Quarterly Volatility 131.7 M |
Check Novocure financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Novocure's main balance sheet or income statement drivers, such as Depreciation And Amortization of 7.8 M, Interest Expense of 7.6 M or Selling General Administrative of 198.1 M, as well as many indicators such as Price To Sales Ratio of 3.41, Dividend Yield of 0.0 or PTB Ratio of 3.75. Novocure financial statements analysis is a perfect complement when working with Novocure Valuation or Volatility modules.
Novocure | Total Stockholder Equity |
Latest Novocure's Total Stockholder Equity Growth Pattern
Below is the plot of the Total Stockholder Equity of Novocure over the last few years. It is the total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders. Novocure's Total Stockholder Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Novocure's overall financial position and show how it may be relating to other accounts over time.
| Total Stockholder Equity | 10 Years Trend |
|
Total Stockholder Equity |
| Timeline |
Novocure Total Stockholder Equity Regression Statistics
| Arithmetic Mean | 250,564,825 | |
| Geometric Mean | 220,317,080 | |
| Coefficient Of Variation | 51.81 | |
| Mean Deviation | 110,516,803 | |
| Median | 217,790,000 | |
| Standard Deviation | 129,827,661 | |
| Sample Variance | 16855.2T | |
| Range | 378.7M | |
| R-Value | 0.69 | |
| Mean Square Error | 9360.5T | |
| R-Squared | 0.48 | |
| Significance | 0 | |
| Slope | 18,925,705 | |
| Total Sum of Squares | 252828.3T |
Novocure Total Stockholder Equity History
About Novocure Financial Statements
Novocure shareholders use historical fundamental indicators, such as Total Stockholder Equity, to determine how well the company is positioned to perform in the future. Although Novocure investors may analyze each financial statement separately, they are all interrelated. The changes in Novocure's assets and liabilities, for example, are also reflected in the revenues and expenses on on Novocure's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Total Stockholder Equity | 416.9 M | 279.7 M |
Additional Tools for Novocure Stock Analysis
When running Novocure's price analysis, check to measure Novocure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novocure is operating at the current time. Most of Novocure's value examination focuses on studying past and present price action to predict the probability of Novocure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novocure's price. Additionally, you may evaluate how the addition of Novocure to your portfolios can decrease your overall portfolio volatility.